GlaxoSmithKline v. State of Louisiana


(U.S., filed August 8, 2018): Arguing that a State cannot invoke sovereign immunity to avoid being bound by a class settlement and, instead, bring a new lawsuit making identical claims when the State was expressly included in the class, received notice of the action and settlement, and did not opt out.

Case settled

On December 18, 2018, the petition for cert was dismissed.

Latest News

View all news